Utilization of optimal cathepsin protease-sensitive linker sequence had significantly enhanced cross-presentation to CD8+ T cells, and vaccination with such SLPs was shown to reduce tumor growth in vivo [49]. This evidence concerns the gene CD8A and neoplasm.